Advances in Aptamer-Based Biomarker Discovery

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Apr 2

PMID 33796540

Citations 27

Authors

Jie Huang

Xinxin Chen

Xuekun Fu

Zheng Li

Yuhong Huang

Chao Liang

Affiliations

Soon will be listed here.

Abstract

The discovery and identification of biomarkers promote the rational and fast development of medical diagnosis and therapeutics. Clinically, the application of ideal biomarkers still is limited due to the suboptimal technology in biomarker discovery. Aptamers are single-stranded deoxyribonucleic acid or ribonucleic acid molecules and can selectively bind to varied targets with high affinity and specificity. Compared with antibody, aptamers have desirable advantages, such as flexible design, easy synthesis and convenient modification with different functional groups. Currently, different aptamer-based technologies have been developed to facilitate biomarker discovery, especially CELL-SELEX and SOMAScan technology. CELL-SELEX technology is mainly used to identify cell membrane surface biomarkers of various cells. SOMAScan technology is an unbiased biomarker detection method that can analyze numerous and even thousands of proteins in complex biological samples at the same time. It has now become a large-scale multi-protein biomarker discovery platform. In this review, we introduce the aptamer-based biomarker discovery technologies, and summarize and highlight the discovered emerging biomarkers recently in several diseases.

Citing Articles

Emerging trends in the cystatin C sensing technologies: towards better chronic kidney disease management.

Raveendran J, Gangadharan D, Bayry J, Rasheed P RSC Adv. 2025; 15(7):4926-4944.

PMID: 39957820 PMC: 11826153. DOI: 10.1039/d4ra07197b.

Aptamer and DNAzyme Based Colorimetric Biosensors for Pathogen Detection.

Liu R, Li J, Salena B, Li Y Angew Chem Int Ed Engl. 2024; 64(4):e202418725.

PMID: 39551709 PMC: 11753613. DOI: 10.1002/anie.202418725.

Proteomics and its application in the research of acupuncture: An updated review.

Zhong Z, Sun M, He M, Huang H, Hu G, Ma S Heliyon. 2024; 10(12):e33233.

PMID: 39022010 PMC: 11253069. DOI: 10.1016/j.heliyon.2024.e33233.

Hope on the Horizon? Aptamers in Diagnosis of Invasive Fungal Infections.

Khodavaisy S, Xu J Genes (Basel). 2024; 15(6).

PMID: 38927669 PMC: 11202631. DOI: 10.3390/genes15060733.

Electrochemical cytosensor utilizing tetrahedral DNA/bimetallic AuPd holothurian-shaped nanoparticles for ultrasensitive non-destructive detection of circulating tumor cells.

Guo H, Fu Y, Chen S, Wei Y, Xie L, Chen M Mikrochim Acta. 2024; 191(6):298.

PMID: 38709403 DOI: 10.1007/s00604-024-06378-1.

References

Young N . Current concepts in the pathophysiology and treatment of aplastic anemia. Hematology Am Soc Hematol Educ Program. 2013; 2013:76-81. PMC: 6610029. DOI: 10.1182/asheducation-2013.1.76. View

Tanai E, Frantz S . Pathophysiology of Heart Failure. Compr Physiol. 2016; 6(1):187-214. DOI: 10.1002/cphy.c140055. View

Chen M, Yu Y, Jiang F, Zhou J, Li Y, Liang C . Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and Therapy. Int J Mol Sci. 2016; 17(12). PMC: 5187879. DOI: 10.3390/ijms17122079. View

Aronson J, Ferner R . Biomarkers-A General Review. Curr Protoc Pharmacol. 2017; 76:9.23.1-9.23.17. DOI: 10.1002/cpph.19. View

Ngo D, Sinha S, Shen D, Kuhn E, Keyes M, Shi X . Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease. Circulation. 2016; 134(4):270-85. PMC: 4963294. DOI: 10.1161/CIRCULATIONAHA.116.021803. View

Fang X, Tan W . Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach. Acc Chem Res. 2009; 43(1):48-57. PMC: 2808443. DOI: 10.1021/ar900101s. View

Welton J, Loveless S, Stone T, von Ruhland C, Robertson N, Clayton A . Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis. J Extracell Vesicles. 2017; 6(1):1369805. PMC: 5614217. DOI: 10.1080/20013078.2017.1369805. View

Mahmud I, Garrett T . Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives. J Am Soc Mass Spectrom. 2020; 31(10):2013-2024. DOI: 10.1021/jasms.0c00238. View

Berezovski M, Lechmann M, Musheev M, Mak T, Krylov S . Aptamer-facilitated biomarker discovery (AptaBiD). J Am Chem Soc. 2008; 130(28):9137-43. DOI: 10.1021/ja801951p. View

10.

Hathout Y, Brody E, Clemens P, Cripe L, DeLisle R, Furlong P . Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A. 2015; 112(23):7153-8. PMC: 4466703. DOI: 10.1073/pnas.1507719112. View

11.

Yiu E, Kornberg A . Duchenne muscular dystrophy. J Paediatr Child Health. 2015; 51(8):759-64. DOI: 10.1111/jpc.12868. View

12.

Hayes M . Parkinson's Disease and Parkinsonism. Am J Med. 2019; 132(7):802-807. DOI: 10.1016/j.amjmed.2019.03.001. View

13.

Posavi M, Diaz-Ortiz M, Liu B, Swanson C, Skrinak R, Hernandez-Con P . Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis. PLoS Med. 2019; 16(10):e1002931. PMC: 6788685. DOI: 10.1371/journal.pmed.1002931. View

14.

Eickhoff H, Malik A . Planar protein arrays in microtiter plates: development of a new format towards accurate, automation-friendly and affordable (A(3)) diagnostics. Adv Biochem Eng Biotechnol. 2012; 133:149-65. DOI: 10.1007/10_2012_148. View

15.

Shangguan D, Li Y, Tang Z, Cao Z, Chen H, Mallikaratchy P . Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A. 2006; 103(32):11838-43. PMC: 1567664. DOI: 10.1073/pnas.0602615103. View

16.

Lyngbakken M, Myhre P, Rosjo H, Omland T . Novel biomarkers of cardiovascular disease: Applications in clinical practice. Crit Rev Clin Lab Sci. 2018; 56(1):33-60. DOI: 10.1080/10408363.2018.1525335. View

17.

Ray P, Rialon-Guevara K, Veras E, Sullenger B, White R . Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker. J Clin Invest. 2012; 122(5):1734-41. PMC: 3336995. DOI: 10.1172/JCI62385. View

18.

Zhang J, Hashimoto M, Kawai K, Murakumo Y, Sato T, Ichihara M . CD109 expression in squamous cell carcinoma of the uterine cervix. Pathol Int. 2005; 55(4):165-9. DOI: 10.1111/j.1440-1827.2005.01807.x. View

19.

Chan M, Efthymios M, Tan S, Pickering J, Troughton R, Pemberton C . Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics. Circulation. 2020; 142(15):1408-1421. PMC: 7547904. DOI: 10.1161/CIRCULATIONAHA.119.045158. View

20.

Shangguan D, Cao Z, Meng L, Mallikaratchy P, Sefah K, Wang H . Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J Proteome Res. 2008; 7(5):2133-9. PMC: 2749249. DOI: 10.1021/pr700894d. View